SCHEMBL6152067

SCHEMBL6152067

CCN(CC)CCNC(=O)Nc1cccc(N(C)C)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 1/20 0.52
MAPT P10636 4/20 0.50
SMN1; SMN2 Q16637 3/20 0.49
MEN1 O00255 3/20 0.49
KMT2A Q03164 3/20 0.49
GAA P10253 2/20 0.49
HTT P42858 1/20 0.49
ALDH1A1 P00352 2/20 0.48
ALOX15 P16050 1/20 0.48
MCHR1 Q99705 5/20 0.47
MAPK1 P28482 1/20 0.47
EPHX1 P07099 3/20 0.46
HDAC6 Q9UBN7 1/20 0.46
NPC1 O15118 1/20 0.45
LMNA P02545 1/20 0.45
TP53 P04637 1/20 0.45
TSHR P16473 1/20 0.45
NFKB1 P19838 1/20 0.45
RAB9A P51151 1/20 0.45
NFKB2 Q00653 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5565031 0.88 CNR1 (0.55) CNR1MAPTSMN1; SMN2MEN1KMT2A
SCHEMBL10781905 0.86 MAPT (0.67) CNR1MAPTSMN1; SMN2MEN1KMT2A
SCHEMBL10780462 0.84 EPHX1 (0.61) CNR1MAPTHTTALDH1A1EPHX1
SCHEMBL5561275 0.80 CNR1 (0.53) CNR1MAPTSMN1; SMN2MEN1KMT2A
SCHEMBL7913072 0.80 KMT2A (0.63) MAPTSMN1; SMN2MEN1KMT2AGAA
SCHEMBL16488794 0.75 MAPT (0.56) MAPTSMN1; SMN2MEN1KMT2AGAA
SCHEMBL7518954 0.75 MAPT (0.67) MAPTSMN1; SMN2MEN1KMT2AGAA
SCHEMBL10897950 0.74 ALDH1A1 (0.65) MAPTSMN1; SMN2MEN1KMT2AGAA
SCHEMBL5565491 0.73 MEN1 (0.46) CNR1MAPTSMN1; SMN2MEN1KMT2A
SCHEMBL13151453 0.73 MEN1 (0.82) CNR1MAPTSMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1333792-A4 NOVEL COUPLER FOR USE IN OXIDATIVE HAIR DYEING P & G CLAIROL INC (US) 2005-08-10 EP disclosed
US-6673966-B2 FOR USE IN HAIR COLORING FORMULATIONS THE PROCTER & GAMBLE COMPANY 2004-01-06 US disclosed
EP-1333792-A1 NOVEL COUPLER FOR USE IN OXIDATIVE HAIR DYEING P & G-Clairol, Inc. (US) 2003-08-13 EP disclosed
US-20020100127-A1 Novel coupler for use in oxidative hair dyeing WELLA OPERATIONS US, LLC 2002-08-01 US disclosed
WO-2002039967-A1 NOVEL COUPLER FOR USE IN OXIDATIVE HAIR DYEING P&G - CLAIROL, INC. (US) 2002-05-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020100127-A1 Novel coupler for use in oxidative hair dyeing CBR1, CBR3, PYCR1 CNR1 328/4885MAPT 4628/4885SMN1; SMN2 4874/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.